Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Lee (Taichung, Taiwan), C. Shih (Taichung, Taiwan). Association of tissue inhibitor of metalloproteinases 2 and 3 polymorphisms with non-small cell Lung cancer. 2791

Member's Comments

No comment yet.

Related content which might interest you: Association of genetic polymorphisms of matrix metalloproteinase (MMP)14 to the susceptibility of non-small cell lung cancer Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011 Tissue inhibitors of metalloproteinase-2 C-303T and G-418C genetic polymorphisms are associated with an increased risk of non-small cell lung cancer in Taiwan Source: Annual Congress 2008 - Biology in thoracic tumours Year: 2008 The association of cyclooxygenase 2 single-nucleotide polymorphisms with susceptibility to and severity of non-small cell lung cancer Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 The association of MMP-7 and MMP-13 genetic polymorphisms with susceptibility to non-small cell lung cancer in Taiwan Source: Annual Congress 2008 - Biology in thoracic tumours Year: 2008 Association between H-RAS T81C genetic polymorphism with non-small cell Lung cancer Source: Virtual Congress 2020 – Biological mechanisms of lung cancer Year: 2020 Association of polymorphisms in the genes of the urokinase plasminogen activation system with susceptibility to and severity of nonsmall cell lung cancer Source: Annual Congress 2009 - Lung cancer biology Year: 2009 Association of Pre-miR-rs2910164 polymorphism with non-small cell lung cancer in an Iranian population Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores Year: 2018 Investigation of survivin gene polymorphism in non-small cell lung cancer patients (NSCLC) Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012 A tissue microarray analysis on the role of chromosome 7 multiplication regarding the EGFR expression in non-small cell lung carcinomas Source: International Congress 2016 – Molecular targets in pulmonary disease Year: 2016 Association of KIR genes and their ligands with non-small cell lung cancer Source: Annual Congress 2010 - Prognostic factors for lung cancer Year: 2010 Cox-2 inhibitors in the treatment of small cell lung cancer patients Source: International Congress 2015 – Advances in the therapy of lung cancer Year: 2015 Simultaneous EGFR and VEGF alterations in non-small cell lung carcinoma based on tissue microarrays Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Proapoptotic effects of PAI-1 protein on lung and prostate cancer cells Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013 Association of the endothelin-1 and endothelin A receptor genetic polymorphisms and non-small cell lung cancer in Taiwan Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Abnormal abundance of senescent fibroblasts in the tumor stroma of non-small cell lung cancer patients Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 EGFRmutations are associated with higher brain metastasis radio-sensitivity than KRAS mutations or wild type EGFR in non-small cell lung cancer patients (NSCLC) Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Molecular signatures of non-small cell lung cancer (NSCLC) obtained from gene expression profiling of the benign bronchial mucosa of smokers with and without NSCLC Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer Year: 2013 Prognostic value of survivin gene promoter polymorphisms in non-small cell lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 A polymorphism, which exists intronic lesion of SLC5A10, affects DRG2 expression and survival outcome of early-stage non-small cell lung cancer Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Expression analysis of miR-21 in Bulgarian patients with non-small cell lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016